Phase 2 obesity co-administration study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide Database lock completed Topline data readout ...

StockNews.com started coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Free Report) in a research report report published on Wednesday. The brokerage issued a sell rating on the biotechnology ...

At the moment AZ's clinical-stage pipeline only lists one candidate for obesity, its large-molecule GLP-1/glucagon dual agonist cotadutide which has reached mid-stage testing for overweight and ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

Small molecules are low molecular weight molecules that include lipids, monosaccharides, second messengers, other natural products and metabolites, as well as drugs and other xenobiotics. They are ...